Compare

Innospec/$IOSP

1D1W1M3M6MYTD1Y5YMAX

About Innospec

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
Ticker
$IOSP
Sector
Materials
Primary listing
NASDAQ
Employees
2,450

Innospec Metrics

BasicAdvanced
$2.4B
19.75
$4.90
0.91
$1.79
1.90%

What the Analysts think about Innospec

Analyst ratings (Buy, Hold, Sell) for Innospec stock.
Analyst projections of the future price of Innospec stock.

Bulls say / Bears say

Innospec delivered broad-based second-quarter growth: revenue rose 12% and all three segments grew, with Oilfield Services revenue up 14% and operating income up 40%. This suggests the recovery is not reliant on just one part of the portfolio. (Innospec)
Repairs, process improvements and upgrades at the North Carolina plants could create an earnings inflection in Performance Chemicals. Management expects these actions, alongside new commercial opportunities, to drive further improvement in the second half of 2026. (Innospec, AP News)
The company has a debt-free balance sheet and $250.2 million of cash, giving it room to invest, pursue acquisitions and continue returning capital. It paid a $0.92 semi-annual dividend and repurchased $6.4 million of shares in the second quarter. (Innospec)
Revenue growth is not yet translating into much higher underlying profit: second-quarter adjusted EBITDA rose only to $50.1 million from $49.1 million, while adjusted EPS was broadly flat. Gross margins fell in both Performance Chemicals and Fuel Specialties, leaving the growth story exposed to further mix or cost pressure. (Innospec)
Cash conversion weakened materially in the first half. Operating cash flow fell to $24.8 million from $38.8 million a year earlier, and second-quarter operating cash flow of $7.2 million was below $16.5 million of capital expenditure. (SEC filing, Innospec)
Performance Chemicals remains supply constrained, so the promised recovery is partly a timing bet: further capacity may not be available until late in the fourth quarter or early 2027. In addition, management said the Oilfield Services completions and production business was below expectations, creating execution risk beyond the DRA expansion. (Daily Political, Exa)
Data summarised monthly by Lightyear AI. Last updated on 26 Sept 2026.

Innospec Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Innospec Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Innospec

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.